Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02725515 · ClinicalTrials.gov registry record · Phase 2
A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus
A Phase 2 study, sponsored by Xencor.
- Completed
- Registry status
- Phase 2
- Development phase
- 105
- Enrollment target
NCT02725515: Completed Phase 2 study, sponsored by Xencor.
NCT02725515 is a Phase 2 study that has completed, run by Xencor. The registered enrollment target is 105 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (21% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02725515, a Phase 2 study, has completed, sponsored by Xencor.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 105 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the ability of XmAb5871 to maintain Systemic Lupus Erythematosus (SLE) disease activity improvement achieved by a brief course of disease-suppressing steroid therapy
Primary Outcome
Landmark proportion of patients without loss of systemic lupus erythematosus disease activity improvement on Day 225
Interventions
- BIOLOGICAL XmAb5871
- BIOLOGICAL Placebo to match XmAb5871
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2016-02-16 |
| Est. Completion | 2018-07-17 |
| Phase | Phase 2 |
What the finished NCT02725515 record still lists
NCT02725515 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (21% lower).
The record links to 0 conditions, and to 2 interventions - of which XmAb5871 is the first listed.
NCT02725515 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02725515 about?
NCT02725515 is a clinical study titled "A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus". The purpose of this study is to determine the ability of XmAb5871 to maintain Systemic Lupus Erythematosus (SLE) disease activity improvement achieved by a brief course of disease-suppressing steroid therapy
What is the current status of trial NCT02725515?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 105 participants. The study started on 2016-02-16. Estimated completion is 2018-07-17.
What interventions are being tested in trial NCT02725515?
The interventions under investigation include: XmAb5871 (BIOLOGICAL), Placebo to match XmAb5871 (BIOLOGICAL).
Who is sponsoring clinical trial NCT02725515?
This trial is sponsored by Xencor, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02725515's enrollment target sits among peer trials
105 650th of 2000 higher than 1,341 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI